SCHEMBL8678705

SCHEMBL8678705

CC(=N)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 5/20 0.46
C3AR1 Q16581 1/20 0.40
NOD1 Q9Y239 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GNPAT O15228 2/20 0.38
NPY4R P50391 4/20 0.36
NPY1R P25929 3/20 0.36
NPY2R P49146 3/20 0.36
NPY5R Q15761 3/20 0.36
ALB P02768 2/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL446929 0.90 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
SCHEMBL468901 0.90 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
SCHEMBL30526285 0.90 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
SCHEMBL6026003 0.90 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
Water SCHEMBL29401510 0.89 FOLH1 (0.48) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
Acetic Acid SCHEMBL28406175 0.89 FOLH1 (0.48) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
Hydrochloric Acid SCHEMBL4422480 0.89 FOLH1 (0.48) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
SCHEMBL9438405 0.89 FOLH1 (0.48) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
SCHEMBL12971304 0.88 C3AR1 (0.43) FOLH1C3AR1NOD1SMN1; SMN2GNPAT
SCHEMBL29005731 0.88 C3AR1 (0.43) FOLH1C3AR1NOD1SMN1; SMN2GNPAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154585-B1 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY GREEN KATHY A (US) 2022-02-23 EP claimed
US-20220040298-A1 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY DARTMOUTH COLLEGE (US) 2022-02-10 US claimed
CN-107073109-B Use of VISTA agonists and antagonists to inhibit or enhance humoral immunity 凯西·A·格林 2021-08-06 CN claimed
US-20170119877-A1 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY IMMUNEXT INC. (US) 2017-05-04 US claimed
EP-3154585-A2 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY Green, Kathy A. (US) 2017-04-19 EP claimed
WO-2015191881-A9 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY GREEN KATHY A (US) 2016-04-21 WO claimed
WO-2015191881-A2 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY GREEN KATHY A (US) 2015-12-17 WO claimed
US-5470847-A Contraceptives by inhibiting ovulation BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-11-28 US claimed
EP-3154585-B1 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY GREEN KATHY A (US) 2022-02-23 EP disclosed
US-20220040298-A1 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY DARTMOUTH COLLEGE (US) 2022-02-10 US disclosed
US-11123426-B2 Use of vista agonists and antagonists to suppress or enhance humoral immunity THE TRUSTEES OF DARTMOUTH COLLEGE (US) 2021-09-21 US disclosed
CN-107073109-B Use of VISTA agonists and antagonists to inhibit or enhance humoral immunity 凯西·A·格林 2021-08-06 CN disclosed
US-20170119877-A1 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY IMMUNEXT INC. (US) 2017-05-04 US disclosed
EP-3154585-A2 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY Green, Kathy A. (US) 2017-04-19 EP disclosed
WO-2015191881-A9 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY GREEN KATHY A (US) 2016-04-21 WO disclosed
WO-2015191881-A2 USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY GREEN KATHY A (US) 2015-12-17 WO disclosed
US-5721278-A Ovulation control by regulating nitric oxide levels BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-02-24 US disclosed
US-5643944-A ADMINISTERING ARGININE, SODIUM NITROPRUSSIDE, NITROGLYCERINE AND IDOSORBIDE MONO OR DINITRATE MIXTURE TO STIMULATE OVULATION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1997-07-01 US disclosed
US-5470847-A Contraceptives by inhibiting ovulation BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-11-28 US disclosed
WO-1995015753-A1 OVULATION CONTROL BY REGULATING NITRIC OXIDE LEVELS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-06-15 WO disclosed